Filing Details

Accession Number:
0001562180-19-005618
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-20 18:49:17
Reporting Period:
2019-11-18
Accepted Time:
2019-11-20 18:49:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1459839 Si-Bone Inc. SIBN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218802 Laura Francis C/O Si-Bone, Inc.
471 El Camino Real, Suite 101
Santa Clara CA 95050
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-18 578 $17.46 89,461 No 4 S Direct
Common Stock Disposition 2019-11-18 437 $17.46 89,024 No 4 S Direct
Common Stock Disposition 2019-11-18 457 $17.46 88,567 No 4 S Direct
Common Stock Disposition 2019-11-18 1,078 $17.54 88,567 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  2. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
  3. Shares purchased pursuant to the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on November 15, 2019
  4. The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.49 to $17.64, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. Includes 39,126 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.